Publication

Development of cyclic peptide inhibitors of coagulation factor XII and matrix metalloproteinase 2

Related publications (77)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Development of cyclic peptide inhibitors of coagulation factor XII and matrix metalloproteinase 2

Graph Chatbot

Chat with Graph Search

A minimalistic cyclic ice-binding peptide from phage display

Small peptide diversification through photoredox-catalyzed oxidative C-terminal modification

Methods for the generation of large combinatorial macrocycle libraries

Chiral Alkyl Amine Synthesis via Catalytic Enantioselective Hydroalkylation of Enecarbamates

De novo development of proteolytically resistant therapeutic peptides for oral administration

Development of Photocatalysts towards the Visible-Light driven C-Terminal Bioconjugation of Peptides and Proteins

Cyclic peptide FXII inhibitor provides safe anticoagulation in a thrombosis model and in artificial lungs

Synthesis of Thiochromans via [3+3] Annulation of Aminocyclopropanes with Thiophenols

Tissue Factor-Independent Coagulation Correlates with Clinical Phenotype in Factor XI Deficiency and Replacement Therapy

Development of cyclic peptide inhibitors of coagulation factor XIa for safer anticoagulation